CD274 and neoplasm: Similarly, in the NEOSTAR trial, an analysis of PD-L1 assessed in tumor cells by IHC showed that, in pretreatment biopsies, PD-L1 was higher in patients with MPR and patients with radiographic responses compared to patients with no MPR and no radiographic response, respectively.